Important Notes:

In January 2021, BEBIG Medical GmbH took over the global production and distribution structures of the HDR brachytherapy products of Eckert & Ziegler BEBIG GmbH including Mick Radio-Nuclear Instruments, Inc.

Below news are related to the HDR brachytherapy business and is quoted originally from the website: https://www.ezag.com/home/press/press_releases/detail/?tx_ttnews%5Btt_news%5D=115&cHash=af46a903a255e3ced4e73ac0e039a3c9

Original Content:

IBt Bebig, a subsidiary of Eckert & Ziegler AG (ISIN DE0005659700) and a leading manufacturer of cancer radiation technology has absorbed all the shares in Bavarian SonoTech GmbH, a minor software developer which has specialised in the planning of radiation therapy.
The company positioned in Neu-Ulm, developed, among others, the software for the use of implants which IBt Bebig has in its range for the treatment of carcinoma of the prostatic gland. Furthermore, the company develops software to plan radiation therapy for the devices used for tumour radiation therapy of IBt Bebig, which are already being used on a broad scale and highly successfully by clinics and radiotherapists throughout the world.
"By the acquisition and the integration of SonoTech we are increasing our share in the value chain for the treatment of prostate cancer and other tumours", as Dr. Edgar Löffler, Member of the Board of Eckert & Ziegler AG and responsible for the segment Therapy explained. "Our additional benefit is the possibility to further develop software in line with our own ideas. We are certainly most pleased that this step has led us to being able to bind the experienced software developers of SonoTech to our Group and are sure this will considerably enhance our competitive standing."

About BEBIG Medical GmbH:

BEBIG Medical GmbH (“BEBIG Medical”) is a global provider of high quality radiation therapy products for cancer treatment headquartered in Berlin, Germany. Preceded by the high dose brachytherapy business unit of Eckert & Ziegler AG, BEBIG Medical has a heritage of more than 40 years’ experience in brachytherapy field and continues to provide affordable healthcare with proven clinical outcomes via strong and viable technology.BEBIG Medical’s US subsidiary, Mick Radio-Nuclear Instruments, Inc., is also known internationally for its manufacturing expertise in the field of applicators and accessories to advance brachytherapy. With a team of professionals and offices in Europe, United States and Asia, the company is empowered to serve customers in more than 65 countries and regions together with a worldwide distribution network.

Contact:

Crystal Chen, Chief Commercial Officer: crystal.chen@bebigmedical.com